SESSIONS WILL BE DIVIDED INTO 3 TRACKS PRIOR TO THE EVENT. DELEGATES WILL BE FREE TO CHOOSE FROM TRACK 1, 2 or 3 AT ANY TIME.
THE DAY WILL START WITH NETWORKING AT 08:00 AND CONCLUDE WITH A NETWORKING SESSION FINISHING AT 17:00.
08:00 – 09:00
Networking
09:00 – 09:20
Welcome and opening remarks
DIAGNOSIS
Joining the dots of patient data, diagnosis and decision making is the holy grail for connected health. What is standing in the way? Is MedTech being implemented fast enough, and is “tech for good” a sustainable model?
From pills to prosthetics, 3D printing seems to be taking healthcare by storm. Could this be the ultimate personalised healthcare? Are implantable medical devices invasive or ingenious? With more stringent regulation around apps and wearables, can we now trust our healthtech?
Can the use of apps and connected health put patients at the centre of their own care? We use wearables for everything from movement to monitoring and mobility. But are our “ables” making us more able? Is the growth in female-focused MedTech a niche or a no-brainer?
Joining the dots of patient data, diagnosis and decision making is the holy grail for connected health. What is standing in the way? Is MedTech being implemented fast enough, and is “tech for good” a sustainable model?
From pills to prosthetics, 3D printing seems to be taking healthcare by storm. Could this be the ultimate personalised healthcare? Are implantable medical devices invasive or ingenious? With more stringent regulation around apps and wearables, can we now trust our healthtech?
Can the use of apps and connected health put patients at the centre of their own care? We use wearables for everything from movement to monitoring and mobility. But are our “ables” making us more able? Is the growth in female-focused MedTech a niche or a no-brainer?
PAUL JONES | Global Head of Population Genomics | Illumina TONU ESKO | Professor of Human Genomics at Institute of Genomics | University of Tartu DAVID CHADWICK | Clinical Manager | LumiraDx Care Solutions JO MASON | R&D Director | Yourgene Health SAMANTHA BRAMLEY| Director of Market Access & Reimbursement | Roche Sequencing Solutions
LORNA GREEN | Chief Operating Officer | Innovation Agency LUELLA TRICKETT | Director, Value & Access | Association of British HealthTech Industries ARAMINTA LEDGER | Director of Campus Development | Cambridge University Health Partners (CUHP) KRISTIN POLMAN | Founder | Shine Digital Consulting ADAM KIRK | Clinical Director | my mhealth
Joining the dots of patient data, diagnosis and decision making is the holy grail for connected health. What is standing in the way?
FACILITATED BY
NEIL EBENEZER | Medical Technologist Specialist | Department for International Trade
PANELLISTS INCLUDE
PAUL ABRAHAMS | Chief Executive Officer | Reacta Biotech NICK KELLY | Chief Executive Officer | Axela Group AMER FASIHI | Chief Executive Officer | Kraydel REBECCA CRALLAN | Head of Cancer Intelligence | Cancer Research UK GILES TULLY | Chief Executive Officer | PinPoint Data Science
Can Medtech with a primary use in the developing world really be a sustainable model?
FACILITATED BY
CERI WILLIAMS| Director of Research and Innovation Development | University of Leeds
PANELLISTS INCLUDE
ELIZABETH FAIRLEY | Chief Operation Officer | Talking Medicines Limited WENDY TINDALE | Consultant Clinical Scientist and Scientific & Innovation Director | Sheffield Teaching Hospitals DAVID JAYNE | Professor of Surgery | University of Leeds PIETRO VALDASTRI | Chair in Robotics & Autonomous Systems | University of Leeds BARRY SINGLETON | Chief Relationship Officer | Scaled Insights
From pills to prosthetics, 3D printing seems to be taking healthcare by storm. Are we really going to see a printer in every pharmacy or hospital?
FACILITATED BY
MIKE HANNAY | Managing Director Medical Technologies | Innovation Facility
PANELLISTS INCLUDE
DAN CLARK | Head of Clinical Engineering | Nottingham University Hospital NHS Trust ASHLEY STRATTON-POWELL | Technical Lead for Orthopaedics, Medicines and Healthcare Products | MHRA RUSSELL HARRIS | Director of the Future Manufacturing Processes Research Group, School of Mechanical Engineering | University of Leeds HENRY PINCHBECK | Chief Executive Officer | 3D Lifeprints
Could implantables be the key to managing chronic diseases?
FACILITATED BY
PARI DATTA | Senior Innovation Consultant | Cambridge Design Partnership
PANELLISTS INCLUDE
MIKE KARIM | Chief Executive Officer | Oxford Endovascular CATHERINE DAVIDSON | Head of Business Development – Life Science | MIDAS RUSS BRADFORD | Co-Founder | Parkinson’s Concierge
MARK CAMPBELL | Independent Healthtech Consultant SAM SHAH | Clinical Director | The Ivory Clinic ARUN PAREKKAT | Digital Analytics Consultant ROBERTO LIDDI | Senior Vice President, Quality Regulatory and IG Compliance | Sensyne Health MICHAEL KIPPING | Innovation Lead – Biomedical Catalyst, Health Sector Team | Innovate UK
Which investors are right for you and your company? Medtech is a broad church in terms of routes to market, potential business model options and financing requirements. Your financing strategy goes hand-in-hand with your business strategy. What type of financing and which investors at what stage is key to making it all work.
FACILITATED BY
LOUISE JOPLING | Commercial Director | Eastern Academic Health Science Network
PANELLISTS INCLUDE
REBECCA TODD | Investment Director | Longwall Venture Partners CHRIS EVANS | Founder | Little Journey JASON MELLAD | Chief Executive Officer | Start Codon SUNIL SHAH | Managing Partner, Therapeutics | o2h Ventures WILL BROOKS | Investment Director | Downing JIM STEEL | Head of Healthcare & Life Sciences Investment Banking team | Peel Hunt LLP
Demonstration of the clear benefits of New Technologies to Patients, Providers of Care, Payers of Care and Optimising selling pricing whilst ensuring the technology reached the patients who need it
RICHARD MOSS | Director and General Manager, UK & Ireland | SI-Bone JOHN WEST | Director | Pellere Health AMANDA HAYHURST | Founder | Gloucester Road Communications
With the ongoing digitalisation of medical devices and the move towards online patient data to unlock the potential for personalised treatments, incorporating cybersecurity elements in the design is becoming a necessity.
In March 2019, the U.S. FDA issued a safety communication about cybersecurity vulnerabilities identified in wireless telemetry technology used for communication in a Medtronic implantable cardiac device. Medtronic subsequently had to develop an update to mitigate these vulnerabilities.
This session aims to provide insight into the aspects of cybersecurity that need to be considered by developers of connected medical devices and deliver some guidance into best practices.
Is the growth trend of female-focussed medtech a niche or a no-brainer?
FACILITATED BY
LINDA DIMARIO | Executive Vice President | Greater Irvine Chamber
PANELLISTS INCLUDE
GIOVANNA FORTE | Chief Executive Officer | Forte Medical KAREN TAYLOR | Director | Deloitte Centre for Health Solutions | Clients & Industries | Deloitte LLP ANGELA HOBBS | Chief Executive Officer and Non-Executive Director | Wilkinson Hall and OBN (UK) ELENA MUSTATEA | Chief Executive Officer | Bold Health
Are patients using apps and connected health to be at the centre of their own care?
FACILITATED BY
MIKE LEWIS | Professor of Life Science Innovation | Innovation Agency North West Coast
PANELLISTS INCLUDE
FAZ CHOWDHURY | Chairman and Chief Executive Officer | Nemaura HAKIM YADI OBE | CEO & Co-founder | Closed Loop Medicine ANDY BLACKWELL | Group Chief Science and Strategy Officer | Ieso LIZ ASHALL-PAYNE | Founding Chief Executive Officer | ORCHA STEPHEN BOURKE | Co-founder | Echo JO HARBY | Director of Information & Involvement | Cancer Research UK
